Company: MDCXW
Filing Date: 2025-12-10
Form Type: DRS
Source: 0001062993-25-017281
Chunk: 4

Company: Medicus Pharma Ltd.
Filing Date: 2025-12-10
Form: DRS
Chunk 4
---
 accuracy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025.

CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD.PURSUANT TO 17 C.F.R. SECTION 200.83

TABLE OF CONTENTS</div>

|                                                       | Page |
| ABOUT THIS PROSPECTUS                                 |    1 |
| TRADEMARKS, TRADE NAMES AND SERVICE MARKS             |    2 |
| MARKET, INDUSTRY AND OTHER DATA                       |    3 |
| CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS |    4 |
| OUR BUSINESS                                          |    6 |
| RISK FACTORS                                          |   10 |
| USE OF PROCEEDS                                       |   11 |
| DILUTION                                              |   12 |
| DESCRIPTION OF THE SECURITIES THAT MAY BE OFFERED     |   13 |
| PLAN OF DISTRIBUTION                                  |   17 |
| LEGAL MATTERS                                         |   21 |
| EXPERTS                                               |   21 |
| WHERE YOU CAN FIND MORE INFORMATION                   |   21 |
| INFORMATION INCORPORATED BY REFERENCE                 |   21 |

<div align='center'>i

CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD.PURSUANT TO 17 C.F.R. SECTION 200.83

ABOUT THIS PROSPECTUS</div>

This prospectus is part of a registration statement filed with the SEC using a "shelf" registration process. Under this shelf process, we may sell the securities described in this prospectus in one or more primary offerings, up to the maximum aggregate dollar amount $100,000,000.

This prospectus provides you with a general description of the securities which may be offered. Each time we offer securities for sale, we will provide a prospectus supplement that contains specific information about the terms of that offering. Any prospectus supplement may also add or update information contained in this prospectus. You should read both this prospectus and any prospectus supplement together with additional information described below under "Where You Can Find More Information" and "Information Incorporated by Reference."

The registration statement that contains this prospectus (including the exhibits thereto) contains additional important information about us and the securities we may offer under this prospectus. Specifically, we have filed certain legal documents that establish the terms of the securities